uniQure N.V. (QURE) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

All participants are in a listen-only mode. After the speaker's remarks, we will conduct a question and answer session. To ask a question at this time, you'll need to press star followed by the number one on your telephone keypad. As a reminder, this conference call is being recorded. I would now like to turn the call over to Kiara Russo, Senior Director of Investor Relations. Thank you. Please go ahead. Good morning, and thank you for joining us for Unicure's third quarter of 2025 earnings call. Earlier this morning, Unicure released its financial results for the third quarter of 2025, and our press release is available on the investors and media section of our website at unicure.com. Our 10Q was also filed with the SEC earlier today. Joining me on the call this morning are Matt Capista, Chief Executive Officer, Dr. Walid Abisab, Chief Medical Officer, Kylie O'Keefe, Chief Customer and Strategy Officer, and Christian Klempt, Chief Financial Officer. After our formal remarks, we'll open the call-up for Q&A. Before we begin, please know that we will be making forward-looking statements during this investor call. All statements other than statements of historical fact are forward-looking statements. They are based on management's beliefs and assumptions and information available to management only as of the date of this conference call. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the factors described in Unicure's most recent SEC filings. Given these risks, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these statements, even if new information becomes available in the future. Now, let me introduce Ma...